Summary
Meredith Redd is a senior scientist and bioengineer with nine years post-PhD experience translating cardiovascular biology into therapeutic candidates, currently driving preclinical programs at Cytokinetics. She has led multidisciplinary teams through the drug development pipeline—from target identification to small and large animal efficacy studies—while mentoring junior scientists and fostering clinical collaborations. Her technical repertoire spans ex vivo and in vivo cardiovascular models, cardiac physiology, human stem cell–derived cardiomyocytes, and tissue engineering, enabling rigorous mechanistic and translational studies. Meredith’s background blends deep academic training (PhD in Bioengineering, University of Washington) with hands-on postdoctoral and teaching roles, giving her both experimental rigor and communication skills. She thrives in collaborative environments and is skilled at converting complex biological insights into pragmatic experimental strategies. A less obvious strength is her cross-disciplinary fluency—comfortable bridging computational biomedical informatics perspectives with wet-lab translational work.
9 years of coding experience
3 years of employment as a software developer
Doctor of Philosophy (PhD), Bioengineering, Doctor of Philosophy (PhD), Bioengineering at University of Washington
The University of Arizona